€217.80
0.88% day before yesterday
Xetra, Dec 27, 05:36 pm CET
ISIN
DE0007165631
Symbol
SRT3
Sector

Sartorius AG Stock price

€217.80
-0.60 0.27% 1M
+1.20 0.55% 6M
-115.40 34.63% YTD
-117.30 35.00% 1Y
-363.60 62.54% 3Y
+22.80 11.69% 5Y
+192.20 750.78% 10Y
Xetra, Closing price Fri, Dec 27 2024
+1.90 0.88%
ISIN
DE0007165631
Symbol
SRT3
Sector

Key metrics

Market capitalization €15.04b
Enterprise Value €20.09b
P/E (TTM) P/E ratio 179.84
EV/FCF (TTM) EV/FCF 71.60
EV/Sales (TTM) EV/Sales 6.04
P/S ratio (TTM) P/S ratio 4.52
P/B ratio (TTM) P/B ratio 5.63
Dividend yield 0.34%
Last dividend (FY23) €0.74
Revenue growth (TTM) Revenue growth -7.87%
Revenue (TTM) Revenue €3.32b
EBIT (operating result TTM) EBIT €486.30m
Free Cash Flow (TTM) Free Cash Flow €280.60m
Cash position €579.20m
EPS (TTM) EPS €1.21
P/E forward 111.65
P/S forward 4.48
EV/Sales forward 5.99
Show more

Create a Free Account to create an Sartorius AG alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Sartorius AG Stock Analysis

Analyst Opinions

23 Analysts have issued a Sartorius AG forecast:

12x Buy
52%
9x Hold
39%
2x Sell
9%

Analyst Opinions

23 Analysts have issued a Sartorius AG forecast:

Buy
52%
Hold
39%
Sell
9%

Financial data from Sartorius AG

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
3,324 3,324
8% 8%
100%
- Direct Costs 1,863 1,863
3% 3%
56%
1,461 1,461
19% 19%
44%
- Selling and Administrative Expenses 403 403
14% 14%
12%
- Research and Development Expense 185 185
4% 4%
6%
872 872
32% 32%
26%
- Depreciation and Amortization 386 386
13% 13%
12%
EBIT (Operating Income) EBIT 486 486
48% 48%
15%
Net Profit 83 83
76% 76%
3%

In millions EUR.

Don't miss a Thing! We will send you all news about Sartorius AG directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sartorius AG Stock News

AD HOC NEWS
20 days ago
Der Labor- und Pharmazulieferer Sartorius DE0007165631 hat für seinen scheidenden Unternehmenschef Joachim Kreuzburg einen Nachfolger gefunden.
EQS
23 days ago
Göttingen, 6. Dezember 2024 Michael Grosse folgt auf Joachim Kreuzburg als Vorstandsvorsitzender der Sartorius AG   Grosse wird Konzernleitung zum 1. Juli 2025 übernehmen Der Aufsichtsrat der Sartorius AG hat in seiner heutigen Sitzung Dr. Michael Grosse zum künftigen Vorstandsvorsitzenden...
EQS
23 days ago
Veröffentlichung einer Insiderinformation gemäß Artikel 17 MAR Michael Grosse wird Vorstandsvorsitzender der Sartorius AG Der Aufsichtsrat der Sartorius AG hat in seiner heutigen Sitzung die Bestellung von Dr. Michael Grosse zum Mitglied des Vorstands und Vorstandsvorsitzenden (CEO) der Gesells...
More Sartorius AG News

Company Profile

Sartorius AG is an international laboratory and process technology provider for the biotech, pharmaceutical, and food industries. It operates through the Bioprocess Solutions and Lab Products and Services divisions. The Bioprocess Solutions division focuses on the major areas of activity of filtration, fluid management, fermentation, and purification. The Lab Products and Services division focuses on lab balances, pipettes, and laboratory water purification systems. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany.

Head office Germany
CEO Joachim Kreuzburg
Employees 14,614
Founded 1870
Website www.sartorius.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today